Trial · NCT04738773
RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response
NCT04738773, Phase 2, Unknown, University of Sao Paulo
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response. Trials, record NCT04738773. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04738773
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response
- NCT number
- NCT04738773
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 40 participants, estimated
- Lead sponsor
- University of Sao Paulo
- Conditions
- Eye Tracking, Gambling Disorder, Naltrexone
- Interventions
- Naltrexone, Placebo
- First posted
- 2021-02-04
- Last updated
- 2021-02-04
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Gambling Follow up scale (GFS) | Day 0 and day 84 | |
| Secondary | Gambling Self-Assessment Scale (G-SAS) | Day 0 and day 84 | |
| Secondary | Gamblers´ Beliefs Questionnaires (GBQ) | Day 0 and day 84 | |
| Secondary | Timeline Follow-Back Method, (TFB) | Day 0 and day 84 | |
| Secondary | Barratt Impulsiveness Scale, version 11 | Day 0 and day 84 | |
| Secondary | Social Adjustment Scale self-report version | Day 0 and day 84 | |
| Secondary | Clinical Global Impression (CGI) | Day 0 and day 84 | |
| Other | Locus of control scale internal- external | Day 0,day 7, and day 84 | |
| Other | Eye Tracking | Day 0, day 7 and day 84 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers30
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04738773
GET https://conductscience.org/api/trials/v1/NCT04738773/papers?page=2